annual SGA:
$321.61M+$11.81M(+3.81%)Summary
- As of today (September 16, 2025), RARE annual SGA is $321.61 million, with the most recent change of +$11.81 million (+3.81%) on December 31, 2024.
- During the last 3 years, RARE annual SGA has risen by +$101.63 million (+46.20%).
- RARE annual SGA is now at all-time high.
Performance
RARE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$87.80M(-100.00%)Summary
- As of today (September 16, 2025), RARE quarterly SGA is $0.00, with the most recent change of -$87.80 million (-100.00%) on June 30, 2025.
- Over the past year, RARE quarterly SGA has dropped by -$80.60 million (-100.00%).
- RARE quarterly SGA is now -100.00% below its all-time high of $87.80 million, reached on March 31, 2025.
Performance
RARE quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$16.11B-$532.93M(-3.42%)Summary
- As of today (September 16, 2025), RARE TTM SGA is -$16.11 billion, with the most recent change of -$532.93 million (-3.42%) on June 30, 2025.
- Over the past year, RARE TTM SGA has dropped by -$16.42 billion (-5288.53%).
- RARE TTM SGA is now -59442.84% below its all-time high of -$27.06 million.
Performance
RARE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RARE Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | -100.0% | -5288.5% |
| 3 y3 years | +46.2% | -100.0% | -6576.5% |
| 5 y5 years | +99.1% | -100.0% | -9431.6% |
RARE Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.2% | -100.0% | at low | -86.6% | at low |
| 5 y | 5-year | at high | +99.1% | -100.0% | at low | -175.4% | at low |
| alltime | all time | at high | >+9999.0% | -100.0% | at low | <-9999.0% | at low |
RARE Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $168.15M(-32.4%) |
| Mar 2025 | - | $87.80M(>+9900.0%) | $248.75M(+4.0%) |
| Dec 2024 | $321.61M(+3.8%) | $0.00(-100.0%) | $239.12M(-24.3%) |
| Sep 2024 | - | $80.35M(-0.3%) | $315.95M(+1.8%) |
| Jun 2024 | - | $80.60M(+3.1%) | $310.51M(-0.3%) |
| Mar 2024 | - | $78.16M(+1.7%) | $311.31M(+0.5%) |
| Dec 2023 | $309.80M(+11.4%) | $76.83M(+2.6%) | $309.80M(+1.3%) |
| Sep 2023 | - | $74.92M(-8.0%) | $305.81M(+1.7%) |
| Jun 2023 | - | $81.40M(+6.2%) | $300.74M(+4.6%) |
| Mar 2023 | - | $76.65M(+5.2%) | $287.47M(+3.4%) |
| Dec 2022 | $278.14M(+26.4%) | $72.85M(+4.3%) | $278.14M(+5.1%) |
| Sep 2022 | - | $69.84M(+2.5%) | $264.72M(+6.4%) |
| Jun 2022 | - | $68.14M(+1.2%) | $248.76M(+6.3%) |
| Mar 2022 | - | $67.31M(+13.3%) | $234.04M(+6.4%) |
| Dec 2021 | $219.98M(+20.3%) | $59.43M(+10.3%) | $219.98M(+4.0%) |
| Sep 2021 | - | $53.88M(+0.9%) | $211.59M(+5.9%) |
| Jun 2021 | - | $53.41M(+0.3%) | $199.83M(+5.9%) |
| Mar 2021 | - | $53.26M(+4.3%) | $188.68M(+3.1%) |
| Dec 2020 | $182.93M(+13.3%) | $51.04M(+21.2%) | $182.93M(+5.3%) |
| Sep 2020 | - | $42.12M(-0.3%) | $173.77M(+0.6%) |
| Jun 2020 | - | $42.25M(-11.1%) | $172.65M(+1.4%) |
| Mar 2020 | - | $47.52M(+13.5%) | $170.21M(+5.4%) |
| Dec 2019 | $161.52M(+26.5%) | $41.88M(+2.1%) | $161.52M(+4.8%) |
| Sep 2019 | - | $41.01M(+3.0%) | $154.12M(+6.9%) |
| Jun 2019 | - | $39.81M(+2.5%) | $144.21M(+6.7%) |
| Mar 2019 | - | $38.83M(+12.6%) | $135.12M(+5.8%) |
| Dec 2018 | $127.72M | $34.48M(+10.9%) | $127.72M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $31.09M(+1.2%) | $130.97M(+6.2%) |
| Jun 2018 | - | $30.72M(-2.3%) | $123.37M(+9.5%) |
| Mar 2018 | - | $31.43M(-16.7%) | $112.66M(+12.8%) |
| Dec 2017 | $99.91M(+53.9%) | $37.72M(+60.5%) | $99.91M(+21.8%) |
| Sep 2017 | - | $23.50M(+17.5%) | $82.00M(+8.3%) |
| Jun 2017 | - | $20.00M(+7.1%) | $75.68M(+7.5%) |
| Mar 2017 | - | $18.68M(-5.7%) | $70.41M(+8.4%) |
| Dec 2016 | $64.94M(+96.8%) | $19.81M(+15.3%) | $64.94M(+14.5%) |
| Sep 2016 | - | $17.18M(+16.6%) | $56.72M(+14.0%) |
| Jun 2016 | - | $14.74M(+11.6%) | $49.77M(+18.3%) |
| Mar 2016 | - | $13.21M(+13.9%) | $42.07M(+27.5%) |
| Dec 2015 | $33.00M(+205.3%) | $11.59M(+13.3%) | $33.00M(+32.9%) |
| Sep 2015 | - | $10.23M(+45.4%) | $24.83M(+41.2%) |
| Jun 2015 | - | $7.04M(+70.1%) | $17.58M(+35.6%) |
| Mar 2015 | - | $4.14M(+20.9%) | $12.96M(+19.9%) |
| Dec 2014 | $10.81M(+142.9%) | $3.42M(+14.8%) | $10.81M(+24.1%) |
| Sep 2014 | - | $2.98M(+23.1%) | $8.71M(+29.5%) |
| Jun 2014 | - | $2.42M(+22.0%) | $6.73M(+56.2%) |
| Mar 2014 | - | $1.99M(+50.3%) | $4.31M(+26.5%) |
| Dec 2013 | $4.45M(+33.1%) | $1.32M(+32.2%) | $3.40M(+14.0%) |
| Sep 2013 | - | $999.00K(>+9900.0%) | $2.98M(+1.1%) |
| Jun 2013 | - | $0.00(-100.0%) | $2.95M(0.0%) |
| Mar 2013 | - | $1.08M(+19.9%) | $2.95M(+57.9%) |
| Dec 2012 | $3.34M(+81.3%) | $903.00K(-6.5%) | $1.87M(+93.5%) |
| Sep 2012 | - | $966.00K(>+9900.0%) | $966.00K(>+9900.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $1.84M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual SGA?
- What is the all time high annual SGA for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual SGA year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly SGA?
- What is the all time high quarterly SGA for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly SGA year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM SGA?
- What is the all time high TTM SGA for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM SGA year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual SGA?
The current annual SGA of RARE is $321.61M
What is the all time high annual SGA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual SGA is $321.61M
What is Ultragenyx Pharmaceutical Inc. annual SGA year-on-year change?
Over the past year, RARE annual SGA has changed by +$11.81M (+3.81%)
What is Ultragenyx Pharmaceutical Inc. quarterly SGA?
The current quarterly SGA of RARE is $0.00
What is the all time high quarterly SGA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly SGA is $87.80M
What is Ultragenyx Pharmaceutical Inc. quarterly SGA year-on-year change?
Over the past year, RARE quarterly SGA has changed by -$80.60M (-100.00%)
What is Ultragenyx Pharmaceutical Inc. TTM SGA?
The current TTM SGA of RARE is -$16.11B
What is the all time high TTM SGA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM SGA is -$27.06M
What is Ultragenyx Pharmaceutical Inc. TTM SGA year-on-year change?
Over the past year, RARE TTM SGA has changed by -$16.42B (-5288.53%)